Friday 1st March 2002 |
Text too small? |
The increased size of the company was evident in the jump in sales for the six-month interim period ending December 2001 from $53.8 million to $121.5 million, with total assets up from $136 million to $277 million and liabilities up from $93 million to $185 million.
After-tax profit was $4.6 million. Directors will consider a dividend at the end of the financial year.
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b